Well-respected scientist and former VP of Research & Preclinical Development for Immunology & Inflammation, with over 30 yrs experience in pharma & biotech. Founder of an innovative consulting firm focused on translational research strategies to help clients evaluate the therapeutic potential and define the mechanistic biology for targets, drug positioning and disease indications. Experience in rare & orphan diseases, immune & inflammatory disorders, fibrosis, infectious diseases and oncology. Proficient in project management, strategic & operational planning, and patenting & licensing issues. Delivers high quality results through innovative approaches and effective management of resources. Strengths in tackling complex problems with significant levels of ambiguity and mitigating high levels of risks.